Overview / Abstract: |
Target Audience The target audience for this initiative includes hematology/oncology physicians and other members of the multidisciplinary cancer care team involved in the management of patients with acute lymphocytic leukemia. Program Overview This activity is the second in a series of four educational activities focusing on the treatment of relapsed/refractory ALL. Dr. Jessica Leonard, from Oregon Health and Science University, discusses diagnoses and treatment options, and will walk through a case study of a patient with Ph+ ALL. Learning Objectives Upon completion of this activity, participants should be better able to: Identify patients who could benefit from CD22-directed ADC therapy using current practice guideline recommendations |
Expiration |
Jul 31, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.5 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Faculty Jessica Leonard, MD Nurse Planner Kirsten Roblee, MHI, BSN, RN, OCN |
Sponsors / Supporters / Grant Providers |
Pfizer |
Keywords / Search Terms |
Relias LLC Relias LLC., Free CME., Relapsed/Refractory Ph+ Free CE CME |